Alpha Genesis

Alpha Genesis

Pre-clinical
Yemassee, United StatesFounded 1999alphagenesisinc.com

Alpha Genesis, Inc. positions itself as America's premier primate research center, offering an integrated suite of services to de-risk and accelerate therapeutic development. With decades of experience and over 100 acres of dedicated facilities, the company combines world-class animal care, state-of-the-art surgical and laboratory platforms, and deep regulatory expertise to generate reproducible data for regulatory submissions. AGI's mission is to accelerate breakthroughs in human and animal health by providing reliable, translational NHP solutions while upholding the highest standards of animal welfare and biosecurity.

Founded
1999
Focus
NeuroscienceRare Disease

AI Company Overview

Alpha Genesis, Inc. positions itself as America's premier primate research center, offering an integrated suite of services to de-risk and accelerate therapeutic development. With decades of experience and over 100 acres of dedicated facilities, the company combines world-class animal care, state-of-the-art surgical and laboratory platforms, and deep regulatory expertise to generate reproducible data for regulatory submissions. AGI's mission is to accelerate breakthroughs in human and animal health by providing reliable, translational NHP solutions while upholding the highest standards of animal welfare and biosecurity.

Technology Platform

Integrated nonhuman primate research ecosystem comprising large-scale specific-pathogen-free (SPF) breeding colonies, GLP-compliant BSL-2 laboratories and surgical suites, CDC-approved quarantine, and a biological materials bank, all operating under AAALAC-accredited animal welfare standards.

Opportunities

AGI is poised for growth due to increasing global demand for nonhuman primates in complex drug development, particularly for cell/gene therapies and biologics.
Opportunities include expanding its specialized service offerings in high-growth areas like gene therapy models and forming strategic, long-term partnerships with large biopharma sponsors.
Leveraging its vast colony data for analytics and insights presents an additional value-creation avenue.

Risk Factors

Key risks include intense regulatory and public scrutiny over animal research, potential biosecurity outbreaks that could devastate its primate colonies, and competitive pressure from international breeders and larger CROs.
Dependency on a stable regulatory environment for animal imports and use is also a significant ongoing challenge.

Competitive Landscape

AGI competes with large, diversified CROs (e.g., Charles River, Labcorp), specialized primate research centers, and international breeding facilities. Its primary differentiation lies in its vertical integration as the largest U.S. breeder with full-service CRO capabilities, offering supply security, consistency, and a strong ethical stance that appeals to sponsors navigating complex regulatory pathways.

Company Info

TypeServices
Founded1999
LocationYemassee, United States
StagePre-clinical
RevenueRevenue Generating

Therapeutic Areas

Broad Spectrum Preclinical SupportImmunologyMetabolic DiseaseGene TherapyNeuroscienceOphthalmologyOrthopedicsRare Disease
SIMILAR COMPANIES
BASi Research Products
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
EydisBio
Pre-clinical · Cambridge
3Spine
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?

Claim your profile to update information, add pipeline data, and connect with investors.

Claim profile